Professor Pat Kendall-Taylor Dr Petros Perros Christopher Neoh Professor Simon Pearce
| Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO | 2008 |
|
Dr Alison Dickinson Professor Pat Kendall-Taylor Dr Petros Perros Christopher Neoh Professor Simon Pearce et al. | Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy | 2008 |
|
Professor Anne Dickinson Professor Pat Kendall-Taylor Dr Petros Perros Christopher Neoh Professor Simon Pearce et al. | Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on the management of GO | 2008 |
|
Dr Karen Adamson Professor Timothy Cheetham Professor Pat Kendall-Taylor Professor Simon Pearce
| The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus | 2007 |
|
Dr Petros Perros Dr Alison Dickinson Professor Pat Kendall-Taylor
| A questionnaire survey on the management of Graves' orbitopathy in Europe | 2006 |
|
Dr Petros Perros Dr Alison Dickinson Professor Pat Kendall-Taylor Christopher Neoh
| Clinical assessment of patients with Graves' orbitopathy: The European Group on Graves' orbitopathy recommendations to generalists, specialists and clinical researchers | 2006 |
|
Dr Petros Perros Professor Pat Kendall-Taylor Christopher Neoh
| A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy | 2005 |
|
Dr Bijayeswar Vaidya Dr Brian Shenton Susan Stamp Dr Alison Dickinson Dr Petros Perros et al. | Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: Absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathy | 2005 |
|
Professor Pat Kendall-Taylor Dr David Price
| Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: Data from KIMS (Pfizer International Metabolic Database) | 2005 |
|
Professor Pat Kendall-Taylor Dr Petros Perros
| Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome | 2005 |
|
Professor Pat Kendall-Taylor Dr Petros Perros
| Early Response to Intravenous Glucocorticoids for Severe Thyroid-Associated Ophthalmopathy Predicts Treatment Outcome. | 2005 |
|
Professor Pat Kendall-Taylor Dr David Price
| The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma | 2005 |
|
Dr Latika Sibal Dr Stephen Ball Dr Vincent Connolly Dr Robert James Philip Kane et al. | Pituitary apoplexy: A review of clinical presentation, management and outcome in 45 cases | 2004 |
|
Dr Bijayeswar Vaidya Dr Helen Imrie Dr Alison Dickinson Dr Petros Perros Professor Pat Kendall-Taylor et al. | CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism | 2003 |
|
Professor Pat Kendall-Taylor Dr Petros Perros Christopher Neoh Dr Alison Dickinson
| Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: The first European Group on Graves' Orbitopathy experience | 2003 |
|
Dr Bijayeswar Vaidya Professor Simon Pearce Stephen Charlton Emeritus Professor Drew Rowan Professor Pat Kendall-Taylor et al. | An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies | 2002 |
|
Dr Bijayeswar Vaidya Professor Simon Pearce Sarah Charlton Nicola Marshall Emeritus Professor Drew Rowan et al. | An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies | 2002 |
|
Professor Pat Kendall-Taylor
| Managing differentiated thyroid cancer | 2002 |
|
Professor Pat Kendall-Taylor
| Managing differentiated thyroid cancer - Better management can improve survival in this curable cancer | 2002 |
|
Dr Latika Sibal Professor Pat Kendall-Taylor Dr Stephen Ball Dr Robert James Professor Simon Pearce et al. | Medical therapy of macroprolactinomas in males: I. prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function | 2002 |
|
Dr Petros Perros Professor Pat Kendall-Taylor
| Medical treatment for thyroid-associated ophthalmopathy | 2002 |
|
Dr Bijayeswar Vaidya Professor Pat Kendall-Taylor Professor Simon Pearce
| The genetics of autoimmune thyroid disease | 2002 |
|
Dr Bijayeswar Vaidya Professor Pat Kendall-Taylor Professor Simon Pearce
| The genetics of autoimmune thyroid disease | 2002 |
|
Dr Bijayeswar Vaidya Dr Helen Imrie Professor Pat Kendall-Taylor Professor Simon Pearce
| Towards defining the susceptibility loci for Graves’ disease : A UK experience | 2002 |
|
Dr Helen Imrie Dr Bijayeswar Vaidya Dr Petros Perros Dr William Kelly Dr Eric Young et al. | Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population | 2001 |
|
Dr Ujjal Mallick George Proud Nigel Jones Dr Helen Lucraft Dr John Fenwick et al. | Lack of antigenicity of recombinant human thyrotropin after multiple injections in patients with differentiated thyroid cancer | 2000 |
|
Professor Pat Kendall-Taylor Janice Gebbie Dr Stephen Turner
| Long-acting octreotide LAR compared with lanreotide SR in the treatment of acromegaly | 2000 |
|
Dr Ujjal Mallick Dr John Fenwick Dr Robert James Dr Sarah Johnson Professor Pat Kendall-Taylor et al. | Northern cancer network guidelines for management of thyroid cancer | 2000 |
|
Dr Robert James Dr Keith Hall Professor Pat Kendall-Taylor
| Optic chiasmal herniation - an under recognized complication of dopamine agonist therapy for macroprolactinoma | 2000 |
|
Dr Ujjal Mallick Dr Helen Lucraft George Proud Dr Petros Perros Dr John Fenwick et al. | Optimizing the management of differentiated thyroid cancer. | 2000 |
|
Dr Bijayeswar Vaidya Professor Simon Pearce Professor Pat Kendall-Taylor
| Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure | 2000 |
|
Professor Pat Kendall-Taylor
| Thyroid function tests - Tests must still be done in possible thyroid dysfunction | 2000 |
|
Professor Pat Kendall-Taylor
| A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis | 1999 |
|
Professor Mark Thomason Professor Nick Girdler Professor Pat Kendall-Taylor Dr Hilary Wastell Emeritus Professor Robin Seymour et al. | An investigation into the need for supplementary steroids in organ transplant patients undergoing gingival surgery: A double-blind, split-mouth, cross-over study | 1999 |
|
Professor Simon Pearce Dr Bijayeswar Vaidya Dr Helen Imrie Dr Petros Perros Dr William Kelly et al. | Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease | 1999 |
|
Professor Pat Kendall-Taylor Alison James Dr Stephen Ball
| Pituitary tumour co-secreting adrenocorticophin and prolactin: clinical, biochemical and radiological response to cabergoline | 1999 |
|
Dr Kelly Britton Professor Pat Kendall-Taylor
| Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome | 1999 |
|
Professor Pat Kendall-Taylor
| Relationship of physical exercise and ageing to growth hormone production | 1999 |
|
Professor Pat Kendall-Taylor Dr Petros Perros
| Severe thyroid eye disease associated with primary hypothyroidism and thyroid-associated dermopathy | 1999 |
|
Professor Simon Pearce Professor Timothy Cheetham Dr Helen Imrie Dr Bijayeswar Vaidya Professor Rudy Bilous et al. | A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1 | 1998 |
|
Dr Robert James Professor Pat Kendall-Taylor Professor Thomas Lennard
| Gallbladder function in acromegalic patients taking long-term octreotide - evidence of rebound hypermotility on cessation of treatment | 1992 |
|